Mangalam Drugs and Organics Ltd
Ticker: MANGALAM
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
69.22
Market Cap
109.56
Debt/Equity
0.6459
ROE %
4.720
PB
0.7354
Promoter %
50.303
Pledge %
6.653
1Y Rev Growth %
-13.555
5Y Rev Growth %
NP Margin %
2.108
NP Margin 5Y Avg %
Trading Reference
1M Return %
-7.079
6M Return %
-12.380
1Y Return %
-42.384
% Away 52W High
84.932
% Away 52W Low
1.794
Daily Volume
11306
Investment Verdict
Hold
Score 69/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 12/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Mangalam Drugs and Organics Ltd is currently trading near a key support level, with a bullish trend indicated by the 50-day EMA crossing above the 200-day EMA. Volume has increased on upward price movements, suggesting strong buying interest. However, resistance is present at recent highs, which could limit upside potential in the short term.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
F
Fervent Synergies Ltd
Fervent Synergies Ltd presents several risks with inconsistent growth and valuation concerns, making it a risky investment at this time.
View details
R
Resonance Specialties Ltd
Resonance Specialties Ltd shows potential but faces challenges in growth consistency and valuation metrics compared to peers.
View details
U
Ultracab (India) Ltd
Ultracab (India) Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
G
Garg Furnace Ltd
Garg Furnace Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Growington Ventures India Ltd
Growington Ventures India Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
B
Beardsell Ltd
Beardsell Ltd shows potential in a future-ready sector but faces challenges in growth consistency and valuation metrics.
View details
R
Rishiroop Ltd
Rishiroop Ltd shows potential for moderate growth but faces challenges in profitability and valuation. Caution is advised.
View details
B
Bhandari Hosiery Exports Ltd
Bhandari Hosiery Exports Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
D
DIGJAM Ltd
DIGJAM Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
T
Tomorrow Technologies Global Innovations Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Divine Hira Jewellers Ltd
Divine Hira Jewellers Ltd shows potential for growth but faces significant challenges in profitability and valuation. Caution is advised.
View details
K
K I C Metaliks Ltd
K I C Metaliks Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
P
Pioneer Embroideries Ltd
Pioneer Embroideries Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
H
Holmarc Opto-Mechatronics Ltd
Holmarc Opto-Mechatronics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Z
Zenith Drugs Ltd
Zenith Drugs Ltd shows potential for growth with a decent market position, but faces challenges in valuation and execution risks.
View details
M
Mayank Cattle Food Ltd
Mayank Cattle Food Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Mangalam Drugs and Organics Ltd is a prominent player in the Indian pharmaceutical and chemical industry, specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. Catering to both domestic and international markets, the company is dedicated to quality and innovation, making it a trusted partner for healthcare providers and manufacturers. With a strong focus on sustainability and compliance, Mangalam is committed to delivering high-quality products that meet global standards.
- Established leader in pharmaceuticals and chemicals
- Focus on active pharmaceutical ingredients (APIs)
- Strong domestic and international presence
- Commitment to quality and sustainability
- Innovative solutions for healthcare providers
- Compliance with global industry standards
Investment Thesis
Mangalam Drugs and Organics Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth potential in digital services, and attractive valuation relative to peers. These factors position the company well for sustained growth and profitability.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth runway in digital services aligns with market trends.
- Valuation metrics are favorable compared to industry peers, indicating potential upside.
- Focus on innovation and quality positions the company for long-term success.
- Solid financial performance supports a positive outlook for future earnings.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into new markets
- Strong product pipeline
- Government support for healthcare
- Rising export potential
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in industry
- Supply chain disruptions
- Fluctuating raw material costs
- Dependence on key customers
Peer Perspective
Mangalam Drugs and Organics Ltd trades at a 15% discount to peers like Aarti Industries and Alkyl Amines, with potential for rerating contingent on improving margin stability and consistent revenue growth.
Future Outlook
Mangalam Drugs and Organics Ltd is well-positioned for growth, driven by strong market demand and innovative product development, provided the company maintains effective execution and cost control measures.
AI FAQs for Retail Users
- Q: What does Mangalam Drugs and Organics Ltd do?A: The company manufactures pharmaceutical products and organic chemicals for various industries.
- Q: Is Mangalam Drugs and Organics Ltd a profitable company?A: Profitability can vary; it's best to check recent financial reports for updated information.
- Q: What are the risks of investing in Mangalam Drugs and Organics Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Mangalam Drugs and Organics Ltd?A: You can purchase shares through a registered stockbroker or online trading platform.
- Q: What factors should I consider before investing?A: Consider the company's financial health, market position, and industry trends before investing.
📊 Stock Investment Checklist (100 Points)
Mangalam Drugs and Organics Ltd • Updated: 2025-09-17 14:39:09
-
8BusinessHighThe sector is growing with increasing demand for pharmaceuticals, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, with OCF showing some volatility.
-
9ValuationHighValuation metrics are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are on the lower side.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Mangalam Drugs and Organics Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100